Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sublingual dosage of specially formulated tablets in the fasting state. Kinetic variables were determined from multiple plasma lorazepam concentrations measured during 48 hr postdose. After intravenous lorazepam, mean (+/- SE) values were: elimination half-life (t 1/2 beta), 12.9 (+/- 0.8) hr; volume of distribution, 1.3 (+/- 0.07) liters/kg; total clearance, 1.21 (+/- 0.1) ml/min/kg. Absorption of intramuscular lorazepam was rapid. Peak plasma levels were reached at 1.15 hr after dosage, with absorption half-life averaging 14.2 (+/- 4.7) min. Absorption or oral and sublingual lorazepam tended to be less rapid than intramuscular injection, although differences were not significant. Times of peak concentration were 2.37, 2.35, and 2.25 hr postdose for trials C,D, and E, respectively; values of absorption half-life were 32.5, 28.5, and 28.7 min. Absolute systemic availability for trials B, C, D, and E averaged 95.9, 99.8, 94.1, and 98.2%, respectively; none of these differed significantly from 100%. Values of t1/2 beta were highly replicable within individuals regardless of the administration route. Thus, sublingual lorazepam is completely absorbed and is a suitable administration route in clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lorazepam | Glucuronidation (24) | NA | 7-26 (39, 40) | NA”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [40]
Citations
Cites
Clinical Pharmacokinetics of Oxazepam and Lorazepam
Greenblatt, D. J. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106020-00001 · Cited by 367
Self-citationOxazepam kinetics: effects of age and sex.
Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32259-7 · Cited by 209
Self-citationPharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680119 · Cited by 197
Self-citationLorazepam kinetics in the elderly
Greenblatt, D. J., ALLEN, M. D., Locniskar, A., Harmatz, J. S., & Shader, R. I. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979261103 · Cited by 153
Self-citationCimetidine spares the glucuronidation of lorazepam and oxazepam
Patwardhan, R. V., Yarborough, G. W., Desmond, P. V., Johnson, R. F., Schenker, S., & Speeg, K. V. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90450-3 · Cited by 126
Analysis of lorazepam and its glucoronide metabolite by electron-capture gas—liquid chromatography
Greenblatt, D. J., Franke, K., & Shader, R. I. (1978) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81896-4 · Cited by 99
Self-citationAmeer, B., & Greenblatt, D. J. (1981) · Drugs · doi:10.2165/00003495-198121030-00001 · Cited by 88
Self-citationSingle- and multiple-dose kinetics of oral lorazepam in humans: The predictability of accumulation
Greenblatt, D. J., ALLEN, M. D., MacLaughlin, D. S., Huffman, D. H., Harmatz, J. S., & Shader, R. I. (1979) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059736 · Cited by 42
Self-citation
Research works printed but not linked: 2
- Greenblatt, 1980, J. Pharmacol. Exp. Ther., 215, 86
- Kraus, 1978, ibid., 24, 411
Cited by
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Self-citationA comparison of rectal diazepam gel and placebo for acute repetitive seizures
Dreifuss, F. E., Rosman, N. P., Cloyd, J. C., Pellock, J. M., Kuzniecky, R. I., Lo, W. D., Matsuo, F., Sharp, G. B., Conry, J. A., Bergen, D. C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382602 · Cited by 287
Pharmacological Management of Acute Agitation
Battaglia, J. (2005) · Drugs · doi:10.2165/00003495-200565090-00003 · Cited by 254
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308113090607 · Cited by 249
Self-citation
Metadata
- Authors
- Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I.
- Affiliations
- Tufts University (US)
- Corresponding author
- Greenblatt, David J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1982-02
- Volume
- 71
- Issue
- 2
- Pages
- 248-252
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2143672875
- Cited by
- 134
- References
- 8
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 3 · 2019: 1 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 4
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- lorazepam, sublingual administration, pharmacokinetics, route of administration, intramuscular injection, intravenous administration, oral tablets, absorption half-life, absolute bioavailability, elimination half-life, volume of distribution, drug clearance
- MeSH terms
- Administration, Oral, Adult, Female, Half-Life, Humans, Injections, Intramuscular, Injections, Intravenous, Kinetics, Lorazepam, Male, Mouth Floor, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam. https://app.cochat.ai/papers/10.1002/jps.2600710227
- The paper
- Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982). Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.2600710227
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.